Skip to main content
Clinical Trials/EUCTR2008-004895-39-GB
EUCTR2008-004895-39-GB
Active, Not Recruiting
N/A

Quantitative Assessment of Myocardial Perfusion with Magnetic Resonance Using an Intravascular Contrast Agent

King's College London0 sitesOctober 31, 2008

Overview

Phase
N/A
Intervention
Not specified
Conditions
Ischemic cardiomyopathy, with inducible ischemia and clinical indication to cardiac revascularization
Sponsor
King's College London
Status
Active, Not Recruiting
Last Updated
14 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 31, 2008
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients referred for MR adenosine stress perfusion, with or without known coronary artery disease, with or without prior myocardial revascularization
  • The subject is \=18 years of age
  • The subject is conscious and able to comply with the study procedures
  • Written informed consent has been obtained
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • Contraindications for MRI
  • Contraindications to Gadolinium based contrast agents (known allergies or a contra indication to Gd
  • chelates or renal insufficiency)
  • Contraindications to Adenosine stress
  • Myocardial infarction \<3 days
  • Unstable angina pectoris
  • Severe arterial hypertension
  • Asthma or severe obstructive pulmonary disease requiring treatment (chronic obstructive pulmonary disease COPD)
  • Sick sinus syndrome or a symptomatic bradycardia, AV block \>IIa, trifascicular block
  • Allergy against vasodilator

Outcomes

Primary Outcomes

Not specified

Similar Trials